12.74
+0.19
+(1.51%)
At close: April 17 at 4:00:01 PM EDT
12.74
0.00
(0.00%)
After hours: April 17 at 4:07:51 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-347,694
-347,694
-357,991
-244,716
-211,389
Investing Cash Flow
-88,756
-88,756
249,308
-141,387
-21,626
Financing Cash Flow
484,304
484,304
17,820
310,670
19,348
End Cash Position
176,535
176,535
128,681
219,544
294,977
Income Tax Paid Supplemental Data
--
--
3
47
210
Capital Expenditure
-15,912
-15,912
-12,939
-17,833
-8,500
Issuance of Capital Stock
499,253
499,253
--
296,215
--
Repayment of Debt
-32,338
-32,338
--
--
--
Free Cash Flow
-363,606
-363,606
-370,930
-262,549
-219,889
12/31/2021 - 12/8/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALEC Alector, Inc.
0.9201
-5.95%
DYN Dyne Therapeutics, Inc.
8.17
+4.34%
PRTA Prothena Corporation plc
9.20
-0.65%
BPMC Blueprint Medicines Corporation
84.69
+3.14%
KYMR Kymera Therapeutics, Inc.
25.97
+3.80%
CGEM Cullinan Therapeutics, Inc.
7.89
+3.68%
REPL Replimune Group, Inc.
8.00
+4.78%
XNCR Xencor, Inc.
9.70
+1.89%
RCUS Arcus Biosciences, Inc.
7.88
+0.38%
PTCT PTC Therapeutics, Inc.
47.39
+2.11%